Characteristics and Response to Crizotinib in ALK-Rearranged, Advanced Non-Adenocarcinoma, Non-Small Cell Lung Cancer (NA-NSCLC) Patients: a Retrospective Study and Literature Review

Overview of attention for article published in Targeted Oncology, September 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,751 followers.

Characteristics and Response to #Crizotinib in ALK-Rearranged, Advanced Non-Adenocarcinoma, Non-Small Cell #LungCancer (NA-NSCLC) Patients https://t.co/MVXJ5818gE https://t.co/YQXFay1H2J

19 Sep 2018

Reply Repost Favourite

Characteristics and Response to Crizotinib in ALK-Rearranged, Advanced Non-Adenocarcinoma, Non-Small Cell Lung Cancer (NA-NSCLC) Patients: a Retrospective Study and Literature Review. #lymphoma #lymsm https://t.co/SIEwDlYQ7d

16 Sep 2018

Reply Repost Favourite